| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |